OBJECTIVE: To examine incidence and outcomes for pediatric rhabdomyosarcoma (RMS). METHODS: The SEER registry was examined for patients with RMS < 20 y old. RESULTS: Overall, 1544 patients were identified for an incidence of 0.4414/100,000 per year. Males outnumbered females 3:2. Tumors were classified as embryonal (67%), alveolar (32%), and pleomorphic (1%). Alveolar and pleomorphic RMS were more common in adolescents, whereas embryonal type was more common in younger children (P = 0.0001). Pleomorphic (47%) and alveolar (39%) RMS commonly presented with distant disease, in contrast to embryonal (25%). Most patients had surgical resection (81%) and radiotherapy (63%). Overall, 5- and 10-y survival was 60% and 57%, respectively. Univariate analysis identified higher survival for age < 10 y, local stage, favorable site, embryonal type, <5 cm tumor size, and surgical resection. Multivariate analysis identified non-embryonal type (HR 1.451), non-favorable site (HR 1.570), no surgery (HR 1.726), age ≥ 10 y (HR 1.734), 1973-1978 diagnosis year (HR 1.730), and distant disease (HR 3.456) as independent predictors of mortality. CONCLUSIONS: Embryonal histology, the most common type of pediatric RMS, presents in young children and has better prognosis than alveolar or pleomorphic types. Patients with embryonal tumors, favorable tumor location, age < 10 y, localized disease, and surgical resection have improved survival.
OBJECTIVE: To examine incidence and outcomes for pediatric rhabdomyosarcoma (RMS). METHODS: The SEER registry was examined for patients with RMS < 20 y old. RESULTS: Overall, 1544 patients were identified for an incidence of 0.4414/100,000 per year. Males outnumbered females 3:2. Tumors were classified as embryonal (67%), alveolar (32%), and pleomorphic (1%). Alveolar and pleomorphic RMS were more common in adolescents, whereas embryonal type was more common in younger children (P = 0.0001). Pleomorphic (47%) and alveolar (39%) RMS commonly presented with distant disease, in contrast to embryonal (25%). Most patients had surgical resection (81%) and radiotherapy (63%). Overall, 5- and 10-y survival was 60% and 57%, respectively. Univariate analysis identified higher survival for age < 10 y, local stage, favorable site, embryonal type, <5 cm tumor size, and surgical resection. Multivariate analysis identified non-embryonal type (HR 1.451), non-favorable site (HR 1.570), no surgery (HR 1.726), age ≥ 10 y (HR 1.734), 1973-1978 diagnosis year (HR 1.730), and distant disease (HR 3.456) as independent predictors of mortality. CONCLUSIONS: Embryonal histology, the most common type of pediatric RMS, presents in young children and has better prognosis than alveolar or pleomorphic types. Patients with embryonal tumors, favorable tumor location, age < 10 y, localized disease, and surgical resection have improved survival.
Authors: Simone Hettmer; Zhizhong Li; Andrew N Billin; Frederic G Barr; D D W Cornelison; Alan R Ehrlich; Denis C Guttridge; Andrea Hayes-Jordan; Lee J Helman; Peter J Houghton; Javed Khan; David M Langenau; Corinne M Linardic; Ranadip Pal; Terence A Partridge; Grace K Pavlath; Rossella Rota; Beat W Schäfer; Janet Shipley; Bruce Stillman; Leonard H Wexler; Amy J Wagers; Charles Keller Journal: Cold Spring Harb Perspect Med Date: 2014-11-03 Impact factor: 6.915
Authors: Catherine J Drummond; Jason A Hanna; Matthew R Garcia; Daniel J Devine; Alana J Heyrana; David Finkelstein; Jerold E Rehg; Mark E Hatley Journal: Cancer Cell Date: 2018-01-08 Impact factor: 31.743
Authors: Sophia Marie Häußler; Carmen Stromberger; Heidi Olze; Georg Seifert; Steffen Knopke; Arne Böttcher Journal: J Cancer Res Clin Oncol Date: 2017-11-16 Impact factor: 4.553
Authors: Christopher F Thompson; Brandon J Kim; Chi Lai; Tristan Grogan; David Elashoff; Maie A St John; Marilene B Wang Journal: Int Forum Allergy Rhinol Date: 2013-02-19 Impact factor: 3.858
Authors: Bassan J Allan; Punam P Parikh; Sofia Diaz; Eduardo A Perez; Holly L Neville; Juan E Sola Journal: HPB (Oxford) Date: 2013-04-22 Impact factor: 3.647